Brain Imaging and Neuroimaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Brain Imaging and Neuroimaging Market is projected to expand from USD 12.64 Billion in 2025 to USD 18.40 Billion by 2031, reflecting a compound annual growth rate of 6.46%. These products encompass a variety of non-invasive diagnostic technologies, such as computed tomography and magnetic resonance imaging, which are designed to visualize the structural and functional status of the central nervous system. The market is primarily propelled by the increasing incidence of neurological disorders and an aging global population, both of which drive the demand for early and precise disease detection. For instance, the World Health Organization reported in 2024 that neurological conditions affected more than one in three people worldwide, underscoring the urgent necessity for specialized diagnostic interventions.

Despite these positive growth drivers, the market encounters significant hurdles due to the high costs associated with acquiring and installing imaging systems. This financial strain is frequently exacerbated by inadequate reimbursement policies and a shortage of skilled radiologists in emerging economies, factors that collectively limit the widespread implementation of these diagnostic tools. Consequently, the substantial capital requirements and workforce constraints continue to pose challenges to the broad adoption of advanced neuroimaging technologies across diverse economic regions.

Market Drivers

A primary catalyst for the Global Brain Imaging and Neuroimaging Market is the rising prevalence of neurological and neurodegenerative diseases. As the global population ages, the frequency of central nervous system conditions is increasing, creating a strong demand for advanced diagnostic modalities that support early intervention. According to the American Cancer Society's January 2025 estimates, approximately 24,820 malignant brain or spinal cord tumors were expected to be diagnosed in the United States that year. This persistent disease burden necessitates the widespread use of high-resolution imaging systems like MRI and CT to assess structural integrity and guide treatment strategies, thereby sustaining market adoption.

Simultaneously, rapid technological progress and the integration of artificial intelligence into diagnostic workflows are significantly fueling market expansion. AI-enabled software has transformed neuroimaging by accelerating image reconstruction, enhancing diagnostic precision, and facilitating automated anomaly detection. As reported by AuntMinnie in July 2025, the FDA listed 211 AI-enabled medical devices cleared between September 2024 and July 2025, with radiology software accounting for 81% of these approvals. These innovations are further supported by substantial investment in research and development; The Transmitter noted in November 2025 that National Institutes of Health (NIH) funding for neuroscience projects reached $10.5 billion in 2024, creating an environment that fosters continuous innovation in brain imaging technologies.

Market Challenges

The substantial costs involved in acquiring and installing imaging systems present a formidable barrier to the growth of the Global Brain Imaging and Neuroimaging Market. Sophisticated diagnostic modalities, such as magnetic resonance imaging and computed tomography, require heavy capital expenditure that covers not only the initial purchase price but also expensive infrastructure modifications and specialized maintenance. This financial magnitude limits market penetration, particularly in smaller healthcare facilities and developing regions where budget constraints are severe. Consequently, many institutions are forced to extend the lifecycle of obsolete equipment rather than investing in modern neuroimaging technologies.

This economic pressure is further intensified by the declining financial stability of healthcare providers, which directly hinders the procurement of new equipment. According to the American Hospital Association, the number of days of cash on hand for hospitals and health systems dropped by 28.3% in 2024 compared to the start of 2022, severely restricting their ability to invest in new medical technology and infrastructure. This reduction in liquidity compels hospitals to deprioritize high-cost imaging investments, thereby directly slowing down revenue growth and adoption rates within the global neuroimaging sector.

Market Trends

The adoption of portable and point-of-care MRI systems is reshaping the market by moving neuroimaging from traditional radiology suites to critical care units and remote environments. This shift meets the urgent need for immediate stroke diagnosis and brain monitoring in patients who cannot be safely transported to high-field magnets, effectively overcoming infrastructure hurdles such as the requirement for radiofrequency shielding. As reported by Hyperfine, Inc. in March 2025, the company sold 48 commercial Swoop portable MRI systems in 2024, resulting in a 17% revenue increase driven by growing hospital adoption. These low-field, wheeled systems remove the need for specialized facilities, thereby democratizing access to neuroimaging and enabling faster clinical decision-making directly at the patient's bedside.

Additionally, the emergence of helium-free and liquid-free MRI technology is gaining momentum as healthcare providers seek to lower operational risks associated with global helium shortages and complex quench pipe infrastructure. This trend involves the deployment of sealed magnet technologies that utilize negligible amounts of coolant, significantly reducing lifecycle costs and siting complexities compared to conventional wet magnets. According to a November 2025 press release from Royal Philips, the company has installed over 2,000 of its 1.5T BlueSeal helium-free MRI systems globally, saving more than 6 million liters of liquid helium to date. This technological evolution ensures continuous uptime during supply disruptions and supports sustainability goals, establishing helium-free magnets as a resilient standard for future brain imaging installations.

Key Players Profiled in the Brain Imaging and Neuroimaging Market

• Varian Medical Systems
• General Electric Company
• Siemens AG
• Philips Healthcare
• Toshiba Medical Systems
• Hitachi Medical Systems
• Esaote SpA
• Sanrad Medical Systems Pvt. Ltd.

Report Scope

In this report, the Global Brain Imaging and Neuroimaging Market has been segmented into the following categories:

Brain Imaging and Neuroimaging Market, by Imaging Type:

• Functional Magnetic Resonance Imaging (fMRI)
• Computed Tomography (CT)
• Positron Emission Tomography (PET)
• Electroencephalography (EEG)
• Magnetoencephalography (MEG)
• Near Infrared Spectroscopy (NIRS);

Brain Imaging and Neuroimaging Market, by End User:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Brain Imaging and Neuroimaging Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Brain Imaging and Neuroimaging Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.